Skip to content

the characteristics of the potential allergens in IgG4-RD patients——a prospective study

the characteristics of the potential allergens in IgG4-RD patients——a prospective study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071312
Enrollment
Unknown
Registered
2023-05-11
Start date
2023-05-05
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4-related disease

Interventions

IgG4-related disease:N/A
sjogren syndrome:N/A

Sponsors

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: a:the inclusion criteria of IgG4-RD patient: 1.1. age=eighteen years old; 1.2. The patients, who come toTongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, diagnosed with IgG4-RD(primary or secondary treatment) and meet the 2019 ACR/EULAR classification criteria. 1.3. Some initially treated patients can be included in the group again if they still meet the above inclusion criteria at the time of relapse even had collected specimens; 1.4. Patients who need blood test for clinical diagnosis and treatment during treatment. b: the inclusion criteria of primary SS patient 1.1. The patients, who come to Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, diagnosed with primary SS and meet the 2016 diagnosis criteria; 1.2. primary treatment; 1.3. Both sex and age distribution were matched with IgG4-RD group; c: the inclusion criteria ofhealthy volunteer 1.1. Both sex and age distribution were matched with IgG4-RD group;

Exclusion criteria

Exclusion criteria: Patients with other rheumatic immune system diseases; Patients suffering from blood-borne infectious diseases; Patients with acute or chronic infection activity; Anemia patients (hemoglobin < 90 g/L); Patients who have used drugs other than steroid hormones, immunosuppressants and biologics.

Design outcomes

Primary

MeasureTime frame
IgG4-related disease;

Secondary

MeasureTime frame
sjogren syndrome;other laboratory index;demographic variable, such as age,sex;healthy person;

Countries

China

Contacts

Public ContactLingli Dong

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology

2752583441@qq.com+86 183 2716 5955

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026